PAC-1 shows efficacy in dog trial
Chasing cancer with dogs — Treating canine cancers is helping researchers learn more about human forms of the disease. Thunder is ...
Read More
Read More
The Phase 1 clinical trial of PAC-1 in human cancer patients has begun!
See listing on clinicaltrials.gov, listen to the interview, watch a PBS documentary about comparative oncology including PAC-1, and watch the ...
Read More
Read More
Congratulations to Sarah Perlmutter
We congratulate Sarah Perlmutter for receiving a NSF Predoctoral Graduate Research Fellowship! ...
Read More
Read More
Congratulations to Evi Llabani
Evi Llabani receives the inaugural C*Star Fellowship from the Cancer Center at Illinois ...
Read More
Read More
Vanquish Oncology, Inc. announces multimillion dollar investment to move PAC-1 to human clinical trials for cancer patients.
Cancer drug tested in pet dogs is now bound for human trials. University of Illinois chemistry professor Paul Hergenrother, left, ...
Read More
Read More
